New Generations of Antibodies and Scaffold Proteins as a Way to Create Highly Selective Conjugates for Oncology
Biomedical Chemistry: Research and Methods · 2026-02 · 9 (1) · e00305
DOI: 10.18097/bmcrm00305 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chemistry: Research and Methods, 2026. Verfasst von I.V. Shulcheva und 1 weiteren Autor:innen. Die Arbeit nennt 137 Literaturangaben.
Abstract (Originalsprache)
This review provides a systematic analysis of modern strategies for developing highly selective therapeutic conjugates for oncology. It examines the evolution from first-generation antibody-drug conjugates (ADCs) to advanced next-generation platforms. The focus is on key conjugate components: targeting modules (bispecific antibodies, small scaffold proteins — affibodies, DARPins, adnectins), linker systems with controlled release, and an expanding arsenal of cytotoxic and cytomodulatory payloads. Special attention is given to innovative technologies, such as PROTAC-ADCs, oligonucleotide conjugates, and photoimmunoconjugates, which enable targeting of "undruggable" molecules and manipulation of intracellular processes. Strategies for site-specific conjugation to obtain homogeneous preparations are analyzed. The conclusion is drawn that the convergence of refined components and novel platforms shapes the future of targeted therapy, aimed significantly at enhancing the therapeutic index and overcoming drug resistance.
Zitieren
APA
Shulcheva, I., & Ulitin, A. (2026). New Generations of Antibodies and Scaffold Proteins as a Way to Create Highly Selective Conjugates for Oncology. Biomedical Chemistry: Research and Methods, 9(1), e00305. https://doi.org/10.18097/bmcrm00305
Vancouver
Shulcheva I, Ulitin A. New Generations of Antibodies and Scaffold Proteins as a Way to Create Highly Selective Conjugates for Oncology. Biomedical Chemistry: Research and Methods. 2026;9(1):e00305. doi:10.18097/bmcrm00305
BibTeX
@article{Shulcheva2026,
author = {Shulcheva, I.V. and Ulitin, A.B.},
title = {New Generations of Antibodies and Scaffold Proteins as a Way to Create Highly Selective Conjugates for Oncology},
journal = {Biomedical Chemistry: Research and Methods},
year = {2026},
volume = {9},
number = {1},
pages = {e00305},
doi = {10.18097/bmcrm00305}
}
EUVIMED